Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents.

@article{Popma2009FrequencyAC,
  title={Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents.},
  author={Jeffrey J. Popma and Laura Mauri and Charles D O'shaughnessy and Paul A. Overlie and Brent T. McLaurin and Alexandra Almonacid and Ajay J. Kirtane and Martin B. Leon},
  journal={Circulation. Cardiovascular interventions},
  year={2009},
  volume={2 2},
  pages={
          133-9
        }
}
BACKGROUND Myocardial infarction (MI) after drug-eluting stent placement has been associated with an unfavorable late prognosis. Although the etiology of periprocedural MI is multifactorial, sidebranch occlusion may be an important contributing factor. We sought to identify the incidence of sidebranch occlusion during zotarolimus-eluting stent (ZES) and paclitaxel-eluting stent (PES) placement and to relate sidebranch occlusion to the occurrence of periprocedural MI. METHODS AND RESULTS… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

One-year follow-up of patients treated with new-generation polymer-based 38 mm everolimus-eluting stent: the P38 study.

  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2015
VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade and MRI visualization of microinfarction.

  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2002